Your session is about to expire
← Back to Search
Corticosteroid Injection vs. Shock Wave Therapy for Tennis Elbow
Study Summary
This trial will compare the effects of two different treatments for chronic lateral epicondylitis (tennis elbow) on pain and function.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I have been diagnosed with a type of inflammatory arthritis.I have been diagnosed with a chronic pain condition like fibromyalgia.I have been diagnosed with tennis elbow due to pain and tenderness on the outer part of my elbow.I am seeing a hand surgeon for pain on the outer side of my elbow.I have not taken steroids (oral or injectable) in the last 3 months.I tried non-surgical treatments for over 4 weeks without improvement.I have nerve compression on the same side of my body.I am under 18 years old.
- Group 1: Kenalog (triamcinolone )
- Group 2: extracorporeal shock wave therapy
- Pivotal Trial - The final step before approval, pivotal trials feature drugs that have already shown basic safety & efficacy.
- All Individual Drugs Already Approved - Therapies where all constituent drugs have already been approved are likely to have better-understood side effect profiles.
- Approved for 10 Other Conditions - This treatment demonstrated efficacy for 10 other conditions.
- Drug Has Already Been Approved - The FDA has already approved this drug, and is just seeking more data.
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
What potential hazards may arise from administering Kenalog (triamcinolone) to patients?
"The safety of Kenalog (triamcinolone) is rated 3 out of 3 since it has undergone Phase 4 trials and been approved for medical practice."
How many participants are in the study group of this clinical trial?
"At this time, there are no more openings for participation in this trial. It was initially published on July 1st of 2015 and last edited in November 23rd of the same year. If you're looking to join another study, lateral epicondylitis has 23 active trials while Kenalog (triamcinolone) has 155 open studies currently accepting patients."
Could you please elucidate the past clinical research that has been conducted with Kenalog (triamcinolone)?
"Presently, 155 clinical trials examining Kenalog (triamcinolone) are underway. Of those studies, 39 have advanced to the 3rd phase of research. Although Chonqqing is home to most of these experiments, 1164 locations across the world are running tests with this medication."
Are any additional volunteers needed for this medical trial?
"A glance at clinicaltrials.gov reveals that this trial is not accepting any more participants, as it was first posted on July 1st 2015 and last updated November 23rd of the same year. However, there are 178 other medical trials actively recruiting patients right now."
What conditions is Kenalog (triamcinolone) commonly prescribed to treat?
"Kenalog (triamcinolone) has been demonstrated to have therapeutic value for treating minor burns, ulcerative colitis, and organ transplantation."
Share this study with friends
Copy Link
Messenger